Page last updated: 2024-08-24

cremophor el and carboplatin

cremophor el has been researched along with carboplatin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Boschma, MU; Giaccone, G; Huizing, MT; Meerum Terwogt, J; Nannan Panday, VR; Schellens, JH; ten Bokkel Huinink, WW; van Tellingen, O; Veenhof, CH1
Beijnen, JH; Mathôt, RA; Schellens, JH; van den Bongard, HJ; van Tellingen, O1
Ellis, AG; Loi, S; Michael, M; Millward, MJ; Rischin, D; Stokes, KH; Webster, LK; Yuen, K1
Chitkara, D; Kumar, N; Mittal, A1
Fransson, M; Gréen, H1

Trials

3 trial(s) available for cremophor el and carboplatin

ArticleYear
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patients.
    Anti-cancer drugs, 2000, Volume: 11, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycerol; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pharmaceutical Vehicles

2000
A randomized cross-over trial to determine the effect of Cremophor EL on the pharmacodynamics and pharmacokinetics of carboplatin chemotherapy.
    Cancer chemotherapy and pharmacology, 2004, Volume: 54, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Carboplatin; Cross-Over Studies; Female; Glycerol; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Surface-Active Agents

2004
Comparison of two types of population pharmacokinetic model structures of paclitaxel.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2008, Feb-05, Volume: 33, Issue:2

    Topics: Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Computer Simulation; Female; Genital Neoplasms, Female; Glycerol; Humans; Middle Aged; Models, Biological; Paclitaxel; Pharmaceutical Vehicles; Reproducibility of Results

2008

Other Studies

2 other study(ies) available for cremophor el and carboplatin

ArticleYear
A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Female; Glycerol; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Surface-Active Agents

2002
HPLC method for the determination of carboplatin and paclitaxel with cremophorEL in an amphiphilic polymer matrix.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Aug-15, Volume: 855, Issue:2

    Topics: Antineoplastic Agents; Calibration; Carboplatin; Chromatography, High Pressure Liquid; Glycerol; Paclitaxel; Polyethylene Glycols; Polyglactin 910; Solvents; Surface-Active Agents

2007